CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 57 filers reported holding CITIUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $117,124 | +23.0% | 100,106 | -17.0% | 0.00% | 0.0% |
Q4 2022 | $95,258 | -23.2% | 120,580 | +17.4% | 0.00% | 0.0% |
Q3 2022 | $124,000 | +10.7% | 102,677 | -15.3% | 0.00% | 0.0% |
Q2 2022 | $112,000 | -62.4% | 121,281 | +41.6% | 0.00% | -66.7% |
Q2 2021 | $298,000 | – | 85,627 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Bridge Compliance, LLC | 154,130 | $105,487 | 0.03% |
CHELSEA COUNSEL CO | 81,300 | $55,642 | 0.03% |
Inspire Advisors, LLC | 186,410 | $127,579 | 0.02% |
Horst & Graben Wealth Management LLC | 75,722 | $51,824 | 0.01% |
GSA CAPITAL PARTNERS LLP | 198,492 | $136 | 0.01% |
Arkadios Wealth Advisors | 100,000 | $68,440 | 0.01% |
Miller Investment Management, LP | 50,000 | $34,220 | 0.01% |
XTX Topco Ltd | 29,077 | $19,900 | 0.00% |
Measured Wealth Private Client Group, LLC | 10,000 | $6,844 | 0.00% |
Pasadena Private Wealth, LLC | 10,965 | $7,504 | 0.00% |